Drs. Calais, Wallis on PSMA PET Guided Salvage Radiotherapy for Prostate Cancer Post-Prostatectomy
By Jérémie Calais, MD, MSc, Christopher Wallis, MD, PhD, FRCSC - Last Updated: June 4, 2023Jérémie Calais, MD, MSc, University of California, Los Angeles, and Christopher Wallis, MD, PhD, University of Toronto, discuss a post-hoc analysis assessing the outcomes of 176 patients treated with PSMA PET guided salvage RT, which demonstrated it to be an effective method for treating both pelvic and extrapelvic recurrent prostate cancer.
Related Posts
Dr. Kommalapati shares her thoughts on the association between tumor-informed MRD and clinical outcomes for MIBC.
Drs. Shilpa Gupta and Vadim Koshkin continue on the EV-103 trial with reference to outcomes and toxicities in cohort K.
Drs. Shilpa Gupta and Vadim Koshkin discuss the EV-103 trial and data, including long-term results for cohort A.
Tanya Jindal expands upon the UNITE study findings relative to biomarkers of response for SG and EV for advanced UC.
Dr. Hutson details the latest 4-year CLEAR data for patients who received 1L lenvatinib plus pembrolizumab for advanced RCC.
630 Madison Ave.
Manalapan, NJ 07726
© 2023 Mashup Media, LLC. All rights reserved.